Target intelligence / Profile preview

Extracellular matrix and tissue surface proteins (ECM proteins)

Target
ECM proteins
Molecular classification
Other, Receptor, Enzyme, Structural protein, Glycoprotein
01

Overview

The extracellular matrix (ECM) and tissue surface proteins represent a diverse collection of macromolecules that provide essential structural scaffolding and biochemical signaling cues to cells within tissues (NCI, 2023). This broad category includes structural fibers such as collagens and elastins, adhesive glycoproteins like fibronectin and laminin, and cell-surface receptors such as integrins that bridge the intracellular and extracellular environments (Hynes & Naba, 2012). These proteins are fundamental to biological processes including cell adhesion, migration, and differentiation, as well as the regulation of growth factor bioavailability (Theocharis et al., 2016). In pathological states, the ECM undergoes significant remodeling; for instance, excessive deposition leads to fibrosis, while enzymatic degradation by matrix metalloproteinases (MMPs) facilitates tumor metastasis (Lu et al., 2012). While the category itself is too broad to be a single therapeutic target, specific components are targeted by various drugs, such as monoclonal antibodies against integrins or enzymes that degrade collagen (StatPearls, 2023). Understanding the matrisome is crucial for developing therapies that can selectively modify the tissue microenvironment in chronic diseases (Naba et al., 2016).

Other names
Extracellular matrixMatrisomeCell surface proteinsECM componentsIntercellular matrix
02

Mechanism of action

Inhibition of cell-matrix adhesion, enzymatic degradation of matrix components, modulation of integrin signaling, and blockade of surface receptor-ligand interactions.

03

Biological functions

Cell adhesionStructural supportSignal transductionCell migrationTissue remodelingGrowth factor sequestration
04

Disease associations

CancerFibrosisCardiovascular diseaseGenetic disordersInflammationArthritis
05

Safety considerations

Impaired wound healingIncreased risk of hemorrhageOff-target systemic tissue degradationImmunogenicity of enzymatic therapiesDisruption of normal tissue homeostasis
06

Interacting drugs

Abciximab

5 more in the full profile.

07

Biomarkers

Matrix metalloproteinase-9 (MMP-9)Type I Collagen C-telopeptide (CTX)Fibronectin EDA isoformC-reactive protein (CRP)Laminin-332

Beyond the preview

Go deeper on Extracellular matrix and tissue surface proteins (ECM proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix and tissue surface proteins (ECM proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call